Clevidipine (the Medicines Company)
Zhang, H.
Current Opinion in Investigational Drugs 3(10): 1474-1478
2002
ISSN/ISBN: 1472-4472 PMID: 12431021 Document Number: 541152
The Medicines Company (under license from AstraZeneca) is developing clevidipine, a short-acting dihydropyridine calcium antagonist, for the potential treatment of peri-operative hypertension. By 1997, the compound was undergoing phase II clinical evaluation by the original developer, AstraZeneca. By March 2002, The Medicines Company was conducting phase III clinical trials.
Document emailed within 1 workday
Related Documents
Evans, A.E. 1976: Anaconda Company and Chile Copper Company v. Overseas Private Investment Corporation. Case No. 16 10 0071 72 American Journal of International Law 70(1): 135-138Tobias, J.D. 2011: Clevidipine for controlled hypotension during spinal surgery in adolescents Middle East Journal of Anaesthesiology 21(2): 269-274
Pijpers, E.L.; Kreijkamp-Kaspers, S.; McGuire, T.M.; Deckx, L.; Brodribb, W.; van Driel, M.L. 2017: Women's questions about medicines in pregnancy - An analysis of calls to an Australian national medicines call centre Australian and New Zealand Journal of Obstetrics and Gynaecology 57(3): 334-341
Orubu, E.Samuel.F.; Okwelogu, C.; Opanuga, O.; Nunn, T.; Tuleu, C. 2016: Access to age-appropriate essential medicines: a retrospective survey of compounding of medicines for children in hospitals in Nigeria and implications for policy development Health Policy and Planning (): -
Coghlan, R.; Stephens, P.; Mwale, B.; Siyanga, M. 2018: A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia Malaria Journal 17(1): 444
Lee, T.H. 1999: My insurance company won't pay for my prescription for Viagra without a letter from my doctor saying that I have been evaluated. As far as I know, I am the only one who can tell whether I have impotence. What does the insurance company want? Harvard Heart Letter: from Harvard Medical School 9(7): 7
Fadahunsi, O. 1990: The State holding corporation in Nigeria : the evolution of the new Nigeria development company Ltd and ODU'a investment company Ltd Public Enterprise 10(1): 131-138
Fadahunsi, O. 1990: The State holding corporation in Nigeria : the evolution of the new Nigeria development company Ltd and ODU'a investment company Ltd Public Enterprise 10(1): 131-138
Beer, A.M.; Schilcher, H.; Loew, D. 2013: Herbal medicines alternative to synthetical medicines MMW Fortschritte der Medizin 155(Suppl 4): 97-99
Ericsson, H.; Tholander, B.; Björkman, J.A.; Nordlander, M.; Regårdh, C.G. 1999: Pharmacokinetics of new calcium channel antagonist clevidipine in the rat, rabbit, and dog and pharmacokinetic/pharmacodynamic relationship in anesthetized dogs Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(5): 558-564
Gini, J.; Amara, A.; Penchala, S.D.; Back, D.J.; Else, L.; Egan, D.; Chiong, J.; Harri, B.I.; Kabilis, E.D.; Pama, P.P.; Stephen, M.; Khoo, S.H. 2019: Widespread use of herbal medicines by people living with human immunodeficiency virus and contamination of herbal medicines with antiretrovirals in Nigeria International Journal of Std and Aids 30(4): 371-377
Wang, H.; Zhang, X-Bo.; Huang, L-Qi.; Guo, L-Ping.; Wang, L.; Zhao, Y-Ping.; Yang, G. 2017: Design and implementation of supply security monitoring and analysis system for Chinese patent medicines supply in national essential medicines Zhongguo Zhong Yao Za Zhi 42(22): 4310-4313
Joshua, I.B.; Passmore, P.R.; Sunderland, B.V. 2016: An evaluation of the Essential Medicines List, Standard Treatment Guidelines and prescribing restrictions, as an integrated strategy to enhance quality, efficacy and safety of and improve access to essential medicines in Papua New Guinea Health Policy and Planning 31(4): 538-546
Haas, L. 1989: Reviews : Managing Your Diabetes (1988). Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285. Patient booklet, 91 pages; flip chart, 87 pages; videotape, 14 modules. Price: Free educational service available through Eli Lilly and Company sales representatives Diabetes Educator 15(1): 90-91
Haas, L. 1989: Reviews : Managing Your Diabetes (1988). Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285. Patient booklet, 91 pages; flip chart, 87 pages; videotape, 14 modules. Price: Free educational service available through Eli Lilly and Company sales representatives Diabetes Educator 15(1): 90-91
Max Gillbricht 1971: Robert R. Sokal and F. James Rohlf: Biometry, The Principles and Practice of Statistics in Biological Research. 89 illus., 56 tab. Folkestone: W. H. Freeman and Company Ltd. 1969. 776 pp., 126 s. F. James Rohlf and Robert R. Sokal: Statistical Tables. 5 illus. Folkestone: W. H. Freeman and Company Ltd. 1969. 253 pp., 64 s (cloth) 24 s (paper) International Review of Hydrobiology 56(2): 328-329
Peters, D.F. 1981: Tailoring first aid to fit company needs Occupational Health and Safety 50(12): 36-40; 42, 52
Donner, M.W. 1999: So you want to start an ambulance company? Emergency Medical Services 28(11): 59-62
Wysong, M. 2000: HazCom on the company Intranet Occupational Health and Safety 69(7): 30-32
Howley, L. 2000: A strategy for company improvement Medical Device Technology 11(2): 33-36